Literature DB >> 32245793

Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma.

Kazutoshi Yamamoto1, Jeffrey R Brender1, Tomohiro Seki1, Shun Kishimoto1, Nobu Oshima1, Rajani Choudhuri1, Stephen S Adler2, Elaine M Jagoda3, Keita Saito1, Nallathamby Devasahayam1, Peter L Choyke3, James B Mitchell1, Murali C Krishna4.   

Abstract

Molecular imaging approaches for metabolic and physiologic imaging of tumors have become important for treatment planning and response monitoring. However, the relationship between the physiologic and metabolic aspects of tumors is not fully understood. Here, we developed new hyperpolarized MRI and electron paramagnetic resonance imaging procedures that allow more direct assessment of tumor glycolysis and oxygenation status quantitatively. We investigated the spatial relationship between hypoxia, glucose uptake, and glycolysis in three human pancreatic ductal adenocarcinoma tumor xenografts with differing physiologic and metabolic characteristics. At the bulk tumor level, there was a strong positive correlation between 18F-FDG-PET and lactate production, while pO2 was inversely related to lactate production and 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) uptake. However, metabolism was not uniform throughout the tumors, and the whole tumor results masked different localizations that became apparent while imaging. 18F-FDG uptake negatively correlated with pO2 in the center of the tumor and positively correlated with pO2 on the periphery. In contrast to pO2 and 18F-FDG uptake, lactate dehydrogenase activity was distributed relatively evenly throughout the tumor. The heterogeneity revealed by each measure suggests a multimodal molecular imaging approach can improve tumor characterization, potentially leading to better prognostics in cancer treatment. SIGNIFICANCE: Novel multimodal molecular imaging techniques reveal the potential of three interrelated imaging biomarkers to profile the tumor microenvironment and interrelationships of hypoxia, glucose uptake, and glycolysis. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32245793      PMCID: PMC7272278          DOI: 10.1158/0008-5472.CAN-19-0928

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Special Report: The 1996 Guide for the Care and Use of Laboratory Animals.

Authors:  J. Derrell Clark; Gerald F. Gebhart; Janet C. Gonder; Michale E. Keeling; Dennis F. Kohn
Journal:  ILAR J       Date:  1997

Review 2.  Understanding the Intersections between Metabolism and Cancer Biology.

Authors:  Matthew G Vander Heiden; Ralph J DeBerardinis
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

3.  Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients.

Authors:  Adam E Hansen; Henrik Gutte; Pernille Holst; Helle H Johannesen; Sofie Rahbek; Andreas E Clemmensen; Majbritt M E Larsen; Christina Schøier; Jan Ardenkjaer-Larsen; Thomas L Klausen; Annemarie T Kristensen; Andreas Kjaer
Journal:  Eur J Radiol       Date:  2018-02-25       Impact factor: 3.528

4.  PET and MRI: Is the Whole Greater than the Sum of Its Parts?

Authors:  Robert J Gillies; Thomas Beyer
Journal:  Cancer Res       Date:  2016-10-11       Impact factor: 12.701

Review 5.  Phenotype and genotype of pancreatic cancer cell lines.

Authors:  Emily L Deer; Jessica González-Hernández; Jill D Coursen; Jill E Shea; Josephat Ngatia; Courtney L Scaife; Matthew A Firpo; Sean J Mulvihill
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

6.  Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.

Authors:  Marion I Menzel; Eliane V Farrell; Martin A Janich; Oleksandr Khegai; Florian Wiesinger; Stephan Nekolla; Angela M Otto; Axel Haase; Rolf F Schulte; Markus Schwaiger
Journal:  J Nucl Med       Date:  2013-04-17       Impact factor: 10.057

7.  Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data.

Authors:  Deborah K Hill; Matthew R Orton; Erika Mariotti; Jessica K R Boult; Rafal Panek; Maysam Jafar; Harold G Parkes; Yann Jamin; Maria Falck Miniotis; Nada M S Al-Saffar; Mounia Beloueche-Babari; Simon P Robinson; Martin O Leach; Yuen-Li Chung; Thomas R Eykyn
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 8.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

9.  Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis.

Authors:  Tieying Dong; Zhaoliang Liu; Qijia Xuan; Zhuozhong Wang; Wenjie Ma; Qingyuan Zhang
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

10.  Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism.

Authors:  Douglas E Biancur; Joao A Paulo; Beata Małachowska; Maria Quiles Del Rey; Cristovão M Sousa; Xiaoxu Wang; Albert S W Sohn; Gerald C Chu; Steven P Gygi; J Wade Harper; Wojciech Fendler; Joseph D Mancias; Alec C Kimmelman
Journal:  Nat Commun       Date:  2017-07-03       Impact factor: 14.919

View more
  8 in total

1.  The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria.

Authors:  Christopher W Schultz; Grace A McCarthy; Teena Nerwal; Avinoam Nevler; James B DuHadaway; Matthew D McCoy; Wei Jiang; Samantha Z Brown; Austin Goetz; Aditi Jain; Valerie S Calvert; Vikalp Vishwakarma; Dezhen Wang; Ranjan Preet; Joel Cassel; Ross Summer; Hoora Shaghaghi; Yves Pommier; Simone A Baechler; Michael J Pishvaian; Talia Golan; Charles J Yeo; Emanuel F Petricoin; George C Prendergast; Joseph Salvino; Pankaj K Singh; Dan A Dixon; Jonathan R Brody
Journal:  Mol Cancer Ther       Date:  2021-08-19       Impact factor: 6.261

Review 2.  (Dis)similarities between the Decidual and Tumor Microenvironment.

Authors:  Jelena Krstic; Alexander Deutsch; Julia Fuchs; Martin Gauster; Tina Gorsek Sparovec; Ursula Hiden; Julian Christopher Krappinger; Gerit Moser; Katrin Pansy; Marta Szmyra; Daniela Gold; Julia Feichtinger; Berthold Huppertz
Journal:  Biomedicines       Date:  2022-05-04

3.  Real-Time insight into in vivo redox status utilizing hyperpolarized [1-13C] N-acetyl cysteine.

Authors:  Kazutoshi Yamamoto; Ana Opina; Deepak Sail; Burchelle Blackman; Keita Saito; Jeffrey R Brender; Ronja M Malinowski; Tomohiro Seki; Nobu Oshima; Daniel R Crooks; Shun Kishimoto; Yu Saida; Yasunori Otowa; Peter L Choyke; Jan H Ardenkjær-Larsen; James B Mitchell; W Marston Linehan; Rolf E Swenson; Murali C Krishna
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.996

4.  Galectin expression detected by 68Ga-galectracer PET as a predictive biomarker of radiotherapy resistance.

Authors:  Dehua Lu; Haoyi Zhou; Nan Li; Yanpu Wang; Ting Zhang; Fei Wang; Ning Liu; Hua Zhu; Jinming Zhang; Zhi Yang; Zhaofei Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-02       Impact factor: 10.057

5.  Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer.

Authors:  Fang Sun; Qiurong Zhu; Tianliang Li; Madiha Saeed; Zhiai Xu; Feisheng Zhong; Rundi Song; Manxiu Huai; Mingyue Zheng; Cen Xie; Leiming Xu; Haijun Yu
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

6.  Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic.

Authors:  Anne Rodallec; Cristina Vaghi; Joseph Ciccolini; Raphaelle Fanciullino; Sebastien Benzekry
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

7.  Biochanin A Inhibits Glioblastoma Growth via Restricting Glycolysis and Mitochondrial Oxidative Phosphorylation.

Authors:  Qiang Dong; Qiao Li; Lei Duan; Hang Yin; Xiaoqing Wang; Yang Liu; Bo Wang; Kun Li; Xuan Yao; Guoqiang Yuan; Yawen Pan
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

8.  TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.

Authors:  Yongchang Chen; Lu Liu; Longzheng Xia; Nayiyuan Wu; Ying Wang; He Li; Xue Chen; Xiaoye Zhang; Zhaoyi Liu; Miaochen Zhu; Qianjin Liao; Jing Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.